The Basel region is one of the world’s leading life-science clusters. Pharmaceutical companies, biotech firms and research ...
Swedish biotech Alligator Bioscience has agreed to sell its CD40-targeting cancer immunotherapy mitazalimab to Canadian drug ...
Fresenius has secured options on 37 biosimilars from WuXi Biologics, significantly expanding its biopharma ambitions through a development agreement. The deal comes as numerous high-selling biologics ...
Beyond the main headlines, European biotech kept moving this week. This edition of Meanwhile in Biotech covers an Alzheimer’s ...
Switzerland-based Idorsia has launched a new pivotal Phase 3 trial of lucerastat in Fabry disease, targeting kidney deposits ...
Spanish biotech ALLOX has closed a €9.4 million ($10.5 million) seed round, led by Asabys with participation from Spanish and ...
Swiss DARPin specialist Molecular Partners is shifting its entire focus to radiopharmaceuticals and plans to cut up to 55 ...
Every Friday, The Leadership Edit follows people taking new roles across European biotech and what their moves may tell us ...
From Berlin biotech NOXXON through a strategic realignment and considerations of cryptocurrency investments, and now back to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results